Drug manufacturers collaborate with anti-doping officers

Nowadays numerous drug manufacturers are ready to collaborate with anti-doping agencies in their war on application of prohibited medications in sports. It sounds strange but this is the reality. In fact, if you review the fate of EPO, you can comprehend why drug manufacturers agree to support efforts of anti-doping officers. EPO is actually an effective remedy for treatment of anemia. A lot of individuals with anemia that have taken EPO have been treated. But what do you think while hearing about this medication? Almost each person associates this remedy just with doping in sports. This drug has been abused by the seven-time winner Lance Armstrong that has cheated the whole world. Thus, EPO is associated only with lying, shame, etc. Looking at this case, pharmaceutical companies try to “defend” their preparations from the similar fate. That’s why they work together with anti-doping officers.
However several pharmaceutical companies began to collaborate with anti-doping agencies earlier, sometimes there were some problems between them. Anti-doping agencies criticized several drug manufacturers for their links to doping.
Today relations between anti-doping agencies and drug manufacturers are better. Pharmaceutical companies share detailed information about new medicines with anti-doping officials. It is precious information for development of detection tests for these medicines. While anti-doping officers learn how medicines are manufactured, how they pass into body, how they work in the body, they can develop more effectual tests for these drugs.
For example, the pharmaceutical company Roche that developed the preparation CERA helped anti-doping officers to elaborate a detection test for it. Later other pharmaceutical companies followed the example of Roche. The company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during the 2012 Olympics.
While relations between anti-doping agencies and huge drug manufacturers become closer, smaller pharmaceutical companies started to cooperate with anti-doping officials as well. While earlier drug manufacturers haven’t desired to discuss about their relations with anti-doping agencies openly, now they don’t fear to announce about this condition.